尽管第一线治疗,但在患有活性复发性复发性多发性硬化症的患者治疗过程
Halina Bartosik-Psujek1, Monika Adamczyk-Sowa2, Alina Kułakowska3
1Department of Neurology, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszow, Poland.
Postepy psychiatrii neurologii
|July 27, 2023
概括
波兰复发性复发性多发性硬化症 (RRMS) 的第一线治疗经常失败,导致治疗中止. 这凸显了需要更早地为RRMS患者提供更有效,高效的药物.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在波兰,复发性复发性多发性硬化症 (RRMS) 的治疗始于一线治疗.
- 目前的第一线治疗方法在RRMS患者中往往是无效的.
- 获得更有效的治疗方法受到现有药物计划标准的限制.
研究的目的:
- 调查波兰RRMS患者的第一线治疗结果.
- 分析那些没有先进疗法的活跃疾病患者的治疗过程.
主要方法:
- 这项研究涉及45个治疗中心的139名RRMS患者.
- 使用标准化表格收集有关治疗进展的医疗数据.
主要成果:
- 贝塔干扰素和二甲基烟酸是最常见的一线RRMS治疗方法.
- 平均治疗持续时间为30.9个月,其中β干扰素持续时间最长.
- 治疗失败是切换或停止RRMS治疗的主要原因.
结论:
- 波兰的一线RRMS治疗主要使用β干扰素和二甲基烟酸.
- 由于治疗失败,观察到高停药和转换率.
- 建议在RRMS患者中提前启动高效疗法.
相关概念视频
Drug Therapy
71
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
71
Classification of Illness
7.6K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
7.6K
Pulmonary Tuberculosis V
201
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
201
Psychosis: Goals of Pharmacotherapy
168
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
168
Electroconvulsive Therapy
69
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
69
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K


